Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
1.
Reproduction ; 146(4): 305-14, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23847262

RESUMO

Multiple exposures to the herbicide atrazine (ATRZ) were shown to suppress the LH surge in both cycling female rats and those ovariectomized (OVX) and primed with estradiol (E2). A single ATRZ administration was found to induce a prompt and marked increase in progesterone (P4). As exogenous P4 is known to have a differential effect on the LH surge depending on its temporal relationship with the surge, it was hypothesized that a single treatment in an OVX, E2-primed rat would augment the surge, whereas several exposures would cause a decrease. Following four daily treatments with 100 mg/kg, LH surge was suppressed. In contrast, a single ATRZ exposure elevated the surge. Two treatments were without effect. The single administration caused a large increase in P4 at 30 and 60 min that was likely attributable to adrenal secretion. Four exposures also elevated P4 after the final treatment, although the duration of the increase was shortened. A single treatment with 0, 10, 30, and 100 mg/kg ATRZ showed similar elevations at the highest concentration in P4, the LH peak, and area under the curve (AUC), whereas four exposures reduced the AUC. An increase at 1 h in the expression of Kiss1 in the anteroventral periventricular nucleus suggests that this regional kisspeptin neuronal population has a role in the ATRZ augmentation of the surge. These data support the hypothesis that ATRZ-induced changes in adrenal P4 can either augment or attenuate the surge depending on the temporal proximity of exposure to the rise in LH.


Assuntos
Glândulas Suprarrenais/metabolismo , Atrazina/farmacologia , Estrogênios/farmacologia , Hormônio Luteinizante/metabolismo , Ovariectomia , Ovário/efeitos dos fármacos , Progesterona/metabolismo , Animais , Feminino , Herbicidas/farmacologia , Kisspeptinas/genética , Kisspeptinas/metabolismo , Ovário/metabolismo , Ovário/cirurgia , RNA Mensageiro/genética , Ratos , Ratos Long-Evans , Reação em Cadeia da Polimerase em Tempo Real , Reação em Cadeia da Polimerase Via Transcriptase Reversa
2.
Toxicol Sci ; 100(1): 194-202, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17728285

RESUMO

The U.S. Environmental Protection Agency is currently validating assays that will be used in a Tier I Screening Battery to detect endocrine disrupting chemicals. A primary concern with the Protocols for the Assessment of Pubertal Development and Thyroid Function in Juvenile Male and Female Rats is that a nonspecific reduction in body weight (BWT) during the exposure period may potentially confound the interpretation of effects on the endocrine endpoints. Wistar rats were underfed 10, 20, 30, or 40% less than the ad libitum food consumed by controls from postnatal days (PNDs) 22 to 42 (females) or PNDs 23 to 53 (males). Terminal BWT of females and males were 2, 4, 12, and 19% and 2, 6, 9, and 19% lower than controls, respectively. In the females, neither the age of pubertal onset nor any of the thyroid hormone endpoints were affected by food restriction (FR) that led to a 12% decrease in BWT. Similarly, none of the male reproductive endpoints examined were altered by FR that led to a 9% BWT decrease. However, decreased triiodothyronine and thyroxin was observed in FR males with a 9% reduced BWT. While these data support the use of the maximum tolerated dose for BWT (10%) for the female protocol, effects on the male thyroid endpoints indicate that a slightly lower limit (

Assuntos
Peso Corporal/efeitos dos fármacos , Disruptores Endócrinos/toxicidade , Privação de Alimentos , Maturidade Sexual , Testes de Toxicidade/métodos , Redução de Peso , Glândulas Suprarrenais/crescimento & desenvolvimento , Animais , Glicemia/metabolismo , Feminino , Genitália Feminina/crescimento & desenvolvimento , Genitália Masculina/crescimento & desenvolvimento , Rim/crescimento & desenvolvimento , Leptina/sangue , Fígado/crescimento & desenvolvimento , Masculino , Tamanho do Órgão , Hipófise/crescimento & desenvolvimento , Ratos , Ratos Wistar , Reprodutibilidade dos Testes , Glândula Tireoide/crescimento & desenvolvimento , Hormônios Tireóideos/sangue , Testes de Toxicidade/normas , Vagina/crescimento & desenvolvimento
3.
Reprod Toxicol ; 23(4): 607-10, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17399945

RESUMO

The purpose of the present study was to examine the distribution of atrazine in the lactating dam and suckling neonate following an acute exposure to either 2 or 4mg/kg 14C-atrazine (14C-ATR) by gavage. 14C-ATR was administered to the nursing dam on postnatal day 3 by oral gavage. Two and a half hours after exposure of the mother to 14C-ATR, the pups were allowed to nurse for 30min. At the end of the nursing period, radiolabelled residues of 14C-ATR [or 14C-chlorotriazines (14C-ClTRI)] were measured in the organs and tissues of the perfused dam and in the stomachs and brains of the rat pups. Both the 2 and the 4mg atrazine treatments resulted in a transfer of approximately 0.007% of 14C-ClTRI to the stomach (indicator of milk content) and 0.0002% to the brains of the offspring following the 30-min nursing period. Three hours following the dose of 14C-ATR, there was a distribution of 14C-ClTRI to the organs of the dam, with the highest amounts in the liver and kidney (1.1 and 0.3% of the administered dose, respectively). Approximately 0.003% of the administered dose was present in three different brain sections of the dam following both doses of 14C-ATR. The results of this study demonstrate that 14C-ClTRI are present in small concentrations in the brain and tissues of the dam (adult female) and provide evidence that atrazine or the metabolites can have direct effects on neuroendrocrine function. The results also provide information for postnatal distribution into the suckling neonate during early lactation.


Assuntos
Atrazina/farmacocinética , Herbicidas/farmacocinética , Lactação , Administração Oral , Animais , Animais Lactentes , Atrazina/administração & dosagem , Atrazina/sangue , Radioisótopos de Carbono/farmacocinética , Relação Dose-Resposta a Droga , Feminino , Herbicidas/administração & dosagem , Herbicidas/sangue , Nível de Efeito Adverso não Observado , Ratos , Ratos Wistar , Medição de Risco , Distribuição Tecidual
4.
Reprod Toxicol ; 23(4): 541-9, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17418526

RESUMO

The disinfection by-product dibromoacetic acid (DBA) has been found in female rats to increase circulating concentrations of both estradiol (E2) and estrone (E1). This effect is apparently due, at least in part, to a suppression in hepatic catabolism. The present study investigated whether DBA, by increasing sex steroid levels, is able either to augment the hypothalamic up-regulation involved in triggering a luteinizing hormone (LH) surge, or to affect the ability of the neurotoxicant sodium dimethyldithiocarbamate (DMDC) to block the surge. Sprague-Dawley rats were gavaged for 14 days with DBA (0-150mg/kg) and ovariectomized on dosing day 11, and at the same time implanted with an estradiol capsule to generate daily LH surges. An injection of 0.1mM/kg DMDC was administered at 13:00h on day 14 and blood was sampled over the afternoon. DBA induced a dose-related increase in total estrogens. For identified surges, areas under the LH curve partitioned into two groups, comprising the two lower (0 and 37.5mg/kg DBA) and the two higher (75 and 150mg/kg) treatment groups. Consequently, low and high DBA groups were compared and found to be significantly different. At 150mg DBA/0.1mM DMDC, the timing of an identifiable LH peak was comparable to non-DMDC females, unlike the 37.5mg DBA/0.1mM DMDC group in which the appearance of peak concentrations was delayed. A significant effect with DBA treatment alone was not present. Results indicated that this exposure to DBA induced a dose-related increase in total estrogen concentrations that paralleled a diminished DMDC blockade of the LH surge. The effect appeared to be attributable to an augmentation in the estrogen-associated up-regulation in brain mechanisms stimulating the surge.


Assuntos
Acetatos/toxicidade , Dimetilditiocarbamato/toxicidade , Disruptores Endócrinos/toxicidade , Ciclo Estral/efeitos dos fármacos , Sistema Hipotálamo-Hipofisário/efeitos dos fármacos , Hormônio Luteinizante/sangue , Ovulação/efeitos dos fármacos , Poluentes Químicos da Água/toxicidade , Animais , Relação Dose-Resposta a Droga , Implantes de Medicamento , Estradiol/sangue , Estrogênios/administração & dosagem , Estrogênios/sangue , Estrona/sangue , Ciclo Estral/sangue , Feminino , Sistema Hipotálamo-Hipofisário/metabolismo , Sistema Hipotálamo-Hipofisário/patologia , Norepinefrina/metabolismo , Tamanho do Órgão/efeitos dos fármacos , Ovariectomia , Ovulação/sangue , Adeno-Hipófise/efeitos dos fármacos , Adeno-Hipófise/patologia , Ratos , Ratos Sprague-Dawley , Purificação da Água
5.
Neurotoxicol Teratol ; 29(3): 368-76, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17258889

RESUMO

Metam sodium (MS) is a soil fumigant and Category II pesticide with a relatively low toxicity in mammals. Previous data have shown an ability to impair reproductive mechanisms in ovariectomized, estradiol-primed rats. A single i.p. injection blocked the luteinizing hormone (LH) surge that in gonadal-intact females initiates the final stages of follicular and oocytic maturation and serves as the trigger for ovulation. The effect paralleled a fall in hypothalamic norepinephrine (NE) and rise in hypothalamic dopamine (DA) that was likely due to a suppression in dopamine-beta-hydroxylase activity. In addition to determining the influence on catecholamine (CA) concentrations from a single oral exposure to MS, the present study explored effects of longer, 3-week treatments on estrous cyclicity, the LH surge, ovulation and hypothalamic CAs. Normally cycling 90 d S-D rats were administered MS (0-200 mg/kg/d, oral) and cyclicity was monitored daily. At the end of the 3rd week, proestrous blood was sampled over the afternoon from regular 4-day cyclers for a determination of LH. These animals were then killed on the following day of estrus (treatment days 21-26) for oocyte retrieval and assessment of hypothalamic CAs. Results showed that shortly after treatment began there occurred a dose-related period of persistent diestrus that typically lasted 8-16 d before regular cycles were reinstated. After 3 weeks, no effects were seen on the magnitude/timing of the LH surge or ovulated oocyte numbers. Anterior and posterior hypothalamic NE and DA were not significantly different from controls, although DA turnover (reflected by the ratio of DOPAC {3,4-dihydroxy-phenylacetic acid} to DA) in both anterior hypothalamic and caudate regions was decreased at all dosages. The data indicate that a 3 week oral exposure to MS induced an initial period of extended diestrus before the resumption of apparently normal reproductive activity, with previously reported CA alterations (apart from a persistent alteration in the DOPAC/DA ratio) being normalized by the end of dosing.


Assuntos
Catecolaminas/metabolismo , Hipotálamo/efeitos dos fármacos , Hipotálamo/metabolismo , Praguicidas/toxicidade , Reprodução/efeitos dos fármacos , Tiocarbamatos/toxicidade , Ácido 3,4-Di-Hidroxifenilacético/metabolismo , Animais , Núcleo Caudado/efeitos dos fármacos , Núcleo Caudado/metabolismo , Dopamina/metabolismo , Relação Dose-Resposta a Droga , Ciclo Estral/efeitos dos fármacos , Feminino , Hormônio Luteinizante/sangue , Norepinefrina/metabolismo , Oócitos/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley
6.
Toxicol Sci ; 94(1): 46-56, 2006 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16940337

RESUMO

This study was conducted to characterize the estrogen receptor (ER)-binding affinities of 50 chemicals selected from among the high production volume chemicals under the U.S. EPA's (U.S. Environmental Protection Agency's) Toxic Substances Control Act inventory. The chemicals were evaluated using the rat uterine cytosolic (RUC) ER-competitive binding assay, with secondary analysis using Lineweaver-Burk plots and slope replots to confirm true competitive inhibition and to determine an experimental K(i). Data from these ER-competitive binding assays represent the types of competitive binding curves that can be obtained when screening chemicals with broad structural diversity. True competitive inhibition was observed in 17 of 50 chemicals. Binding affinities were much lower than that of estradiol (E(2)) with K(i) concentrations ranging from 0.6 to 373 microM as compared with that of E(2) (0.77 nM). Other chemicals that appeared to displace radiolabeled E(2) binding to ER were, in fact, found not to be competitive inhibitors in the secondary K(i) experiments. These seven chemicals likely altered the stability of the assay by changing the buffer pH, denaturing ER, or disrupting the ER-binding kinetics. Thus, several conditions that may confound interpretation of RUC ER-binding assay data are illustrated. For another group of eight chemicals, neither an IC(50) nor K(i) could be determined due to solubility constraints. These chemicals exhibited slight (20-40%) inhibition at concentrations of 10-100 microM, suggesting that they could be competitors at very high concentrations, yet K(i) experiments were not possible as the limit of chemical solubility in the aqueous assay buffer was well above the IC(50). An additional 18 of the 50 chemicals were classified as nonbinders because in concentrations up to 100 microM they produced essentially no displacement of radiolabeled E(2). These results show that although the ER-competitive binding assay is a valuable tool for screening chemicals, secondary tests such as a double reciprocal Lineweaver-Burk experiment with slope replot should be used to confirm true competitive inhibition. This information will be useful for the ongoing validation of the RUC ER-competitive binding assay under the U.S. EPA's Endocrine Disruptor Screening Program, as well as to support research efforts to develop computational models designed to identify chemicals with the ability to bind to ER.


Assuntos
Substâncias Perigosas/metabolismo , Receptores de Estrogênio/metabolismo , Animais , Ligação Competitiva , Citosol/química , Citosol/metabolismo , Feminino , Cinética , Estrutura Molecular , Ratos , Relação Estrutura-Atividade , Útero/química , Útero/metabolismo
7.
Toxicol Sci ; 84(1): 38-48, 2005 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15601673

RESUMO

Molinate, a thiocarbamate herbicide, has been reported to impair reproductive capability in the male rat and alter pregnancy outcome in a two-generation study. Published data are lacking on the effects of acute exposure to molinate in the female. Based on this work and our previous observations with related dithiocarbamate compounds, we hypothesized that a single exposure to molinate during the critical window for the neural trigger of ovulation on the day of proestrus (PRO) would block the luteinizing hormone (LH) surge and delay ovulation. To examine the effect of molinate on the LH surge, ovariectomized (OVX) rats were implanted with Silastic capsules containing estradiol benzoate to mimic physiological levels on proestrus. Doses of 25 and 50 mg/kg molinate significantly suppressed LH and prolactin secretion. Intact regularly cycling females gavaged with 0, 25, or 50 mg/kg molinate at 1300 h on PRO were examined on estrus or estrus +1 day for the presence of oocytes in the oviduct. All control females had oocytes in the oviduct on estrus. Molinate doses of 6.25 to 50 mg/kg delayed ovulation for 24 h. Estrous cyclicity was examined after daily exposure to 50 mg/kg (21 days). Estrous cyclicity was irregular in the molinate group, showing extended days in estrus. Two experiments were conducted to determine whether molinate blocked the LH surge via a central nervous system (CNS) mode of action or via an alteration in pituitary response. In the first experiment, we evaluated the release of LH in control and molinate-treated rats after a bolus dose of exogenous GnRH. Luteinizing hormone release was comparable in the two groups, suggesting that the effect of molinate is centrally mediated. To further examine the potential role of the CNS, we examined the pulsatile release of LH present in the long-term OVX females. In this model, the pulsatile pattern of LH secretion is directly correlated with GnRH release from the hypothalamus. A significant decrease in the LH pulse frequency was observed in molinate-treated females. These results indicate that molinate is able to delay ovulation by suppressing the LH surge on the day of proestrus and that the brain is the primary target site for the effects on pituitary hormone secretion.


Assuntos
Azepinas/toxicidade , Herbicidas/toxicidade , Sistemas Neurossecretores/efeitos dos fármacos , Ovulação/efeitos dos fármacos , Tiocarbamatos/toxicidade , Animais , Encéfalo/enzimologia , Colinesterases/sangue , Colinesterases/metabolismo , Dopamina/metabolismo , Relação Dose-Resposta a Droga , Implantes de Medicamento , Estrogênios/administração & dosagem , Estrogênios/farmacologia , Ciclo Estral/efeitos dos fármacos , Feminino , Hormônio Liberador de Gonadotropina/metabolismo , Hipotálamo/metabolismo , Hormônio Luteinizante/sangue , Norepinefrina/metabolismo , Ovariectomia , Hipófise/metabolismo , Gravidez , Prolactina/sangue , Ratos , Ratos Long-Evans , Fatores de Tempo
8.
Toxicol Sci ; 76(1): 190-200, 2003 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-12970575

RESUMO

We showed previously that the chlorotriazine herbicide, atrazine (ATR), delays the onset of pubertal development in female rats. ATR and its biotransformation by-products are present in soil and groundwater. Since current maximum contaminant levels are set only for ATR, it is important to determine whether these by-products can also alter pubertal development and possibly pose a cumulative exposure hazard. We evaluated the effects of two ATR by-products, diamino-s-chlorotriazine (DACT) and hydroxyatrazine (OH-ATR), and a structurally similar chlorotriazine, propazine (PRO), on female pubertal development. Rats were gavaged from postnatal days (PNDs) 22 through PND 41 with DACT (16.7, 33.8, 67.5, 135 mg/kg), OH-ATR (22.8, 45.7, 91.5, 183 mg/kg), or PRO (13, 26.7, 53, 106.7, 213 mg/kg). The dose range for each chemical was selected as the molar equivalent of ATR (12.5, 25, 50, 100, 200 mg/kg). The females were monitored daily for vaginal opening (VO) and killed on PND 41. DACT, a by-product of ATR that occurs in the environment and is also the primary chlorinated metabolite of ATR in animal tissue, delayed VO by 3.2, 4.8, and 7.6 days compared to the controls (33.1 +/- 0.4 (SE) days of age) following exposure to 33.8, 67.5, and 135 mg/kg, respectively. The no effect level (NOEL) for DACT (16.7 mg/kg) was identical to the equimolar NOEL for ATR (25 mg/kg). Although the body weight (BW) on PND 41 was reduced by the high dose of DACT (8.4% reduction), this reduction did not exceed the criteria for selecting the maximum tolerated dose (e.g., a dose that causes >10% decrease in BW at necropsy). None of the lower doses of DACT caused a significant difference in BW gain. Additionally, 33.8, 67.5, and 135 mg/kg of DACT significantly increased the BW on the day of VO. PRO (107 or 213 mg/kg) delayed VO by 4 days but did not alter the BW on PND 41. While no significant delays in pubertal development were observed in two separate dose-response studies with doses ranging up to 183 mg/kg (OH-ATR), a minor but statistically significant delay in the onset of puberty in a pilot study using OH-ATR raises the possibility that an effect might occur following exposure to higher doses. However, it is clear from these data that OH-ATR has a much lower potency when compared with equimolar doses of DACT and PRO. Together, these data demonstrate that PRO and DACT can delay the onset of puberty in the female rat at doses equimolar to ATR and provide the scientific basis for the use of additivity in the upcoming risk assessments.


Assuntos
Atrazina/análogos & derivados , Atrazina/toxicidade , Herbicidas/metabolismo , Efeitos Tardios da Exposição Pré-Natal , Maturidade Sexual/efeitos dos fármacos , Triazinas/toxicidade , Vagina/efeitos dos fármacos , Administração Oral , Animais , Atrazina/metabolismo , Biotransformação , Peso Corporal/efeitos dos fármacos , Feminino , Nível de Efeito Adverso não Observado , Tamanho do Órgão/efeitos dos fármacos , Gravidez , Ratos , Ratos Wistar , Hormônios Tireóideos/sangue , Triazinas/metabolismo , Vagina/crescimento & desenvolvimento
9.
Toxicol Sci ; 78(1): 144-55, 2004 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-14999130

RESUMO

DE-71, a commercial mixture, was used to test the sensitivity of the female and male pubertal protocol to detect thyroid active chemicals. These protocols are being evaluated for the U.S. EPA's Endocrine Disruptor Screening Program as part of a Tier I Screening Battery. To examine the ability of these protocols to screen for chemicals that induce the clearance of thyroid hormone, we examined male and female Wistar rats following DE-71 exposure. Rats were gavaged daily with 0, 3, 30, or 60 mg/kg DE in corn oil from postnatal day (PND) 23-53 in the male or PND 22-41 in the female. The temporal effects of DE-71 on liver enzymes and thyroid hormones were measured in another group of males and females following only 5 days of dosing (PND 21 to 26 in females and PND 23 to 28 in males). Serum T4 was significantly decreased at 30 and 60 mg/kg following the 5-day exposures and in the 21-day exposed females. Doses of 3, 30, and 60 mg/kg decreased T4 in 31-day exposed males. Serum T3 was decreased and TSH elevated by 30 and 60 mg/kg in the 31-day exposed males only. Decreased colloid area and increased follicular cell heights (indicative of the hypothyroid state) were observed in thyroids of the 60 mg/kg groups of 20- and 31-day exposed female and males. Increased liver-to-body weight ratios coincided with a significant induction of uridinediphosphate-glucuronosyltransferase (UDGPT; two to four-fold), and ethoxy- and pentoxy-resorufin-O-deethylase (EROD and PROD) at the two highest doses in all exposures. Of the androgen dependent tissues in the 31-day exposed males, seminal vesicle (SV) and ventral prostate (VP) weights were reduced at 60 mg/kg, while testes and epididymal weights were not affected. Preputial separation (PPS) was also significantly delayed by doses of 30 and 60 mg/kg. In the female, the 60 mg/kg dose also caused a significant delay in the age of vaginal opening. Based upon the thyroid hormone response data, this study provides evidence that the 31-day alternative Tier 1 male protocol is a more sensitive test protocol than the 5-day or female pubertal protocol for thyrotoxic agents that act via up-regulation of hepatic metabolism. This apparent greater sensitivity may be due a greater body burden attained following the longer dosing regimen as compared with that of the female protocol, or to gender specific differences in thyroid hormone metabolism. Also, the delay in PPS and reduction in SV and VP weights may indicate a modification or inhibition of endogenous androgenic stimulation directly by DE-71 or a secondary effect that occurs in response to a DE-induced change in thyroid hormones.


Assuntos
Misturas Complexas/toxicidade , Doenças do Sistema Endócrino/induzido quimicamente , Hidrocarbonetos Bromados/toxicidade , Éteres Fenílicos/toxicidade , Bifenil Polibromatos/toxicidade , Maturidade Sexual/efeitos dos fármacos , Animais , Peso Corporal/efeitos dos fármacos , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Determinação de Ponto Final , Feminino , Éteres Difenil Halogenados , Masculino , Microssomos Hepáticos/efeitos dos fármacos , Microssomos Hepáticos/enzimologia , Tamanho do Órgão/efeitos dos fármacos , Pênis/efeitos dos fármacos , Pênis/crescimento & desenvolvimento , Gravidez , Radioimunoensaio , Ratos , Ratos Wistar , Glândula Tireoide/efeitos dos fármacos , Glândula Tireoide/patologia , Hormônios Tireóideos/sangue , Testes de Toxicidade , Vagina/efeitos dos fármacos , Vagina/crescimento & desenvolvimento
10.
Life Sci ; 73(24): 3123-38, 2003 Oct 31.
Artigo em Inglês | MEDLINE | ID: mdl-14550852

RESUMO

Chlorotriazines interact with undifferentiated PC12 cells in vitro to modulate catecholamine synthesis and release, but the mechanism(s) responsible for this effect had not been determined. In this study we evaluated the effect of atrazine, simazine and cyanazine on the protein expression of the enzymes responsible for the synthesis of dopamine [tyrosine hydroxylase (TH)] and norepinephrine [dopamine-beta-hydroxylase (DbetaH)]. We also examined the possible intracellular pathway associated with chlorotriazine-induced changes in catecholamine synthesis and release. Incubating PC12 cells in the presence of 100 microM atrazine and simazine decreased intracellular dopamine (DA), norepinephrine (NE) concentration and NE release, and the protein expression of TH (approximately 20%) and DbetaH (approximately 50 and 25%, respectively) after 12-24 h exposure. In contrast, cyanazine (100 microM) stimulated intracellular and released NE concentration, and the protein expression of TH (approximately 20%) and DbetaH (approximately 225%) after 12-36 h exposure. Simultaneous exposure to the essential TH co-factors (iron and tetrahydrobiopterine) was ineffective in altering cellular DA. Agents known to enhance TH and DbetaH transcription, phosphorylation or activity (e.g., 8-bromo cAMP, forskolin or dexamethasone) reversed the inhibitory effects of atrazine and simazine on the NE. Again, in contrast to atrazine and simazine, cyanazine attenuated catecholamine-depleting effect of alpha-Methyl-p-tyrosine (alphaMpT) on NE. Both DA and NE synthesis can be altered by the chlorotriazines and suggest these occur via an alteration of the synthetic enzymes TH and DbetaH.


Assuntos
Dopamina/metabolismo , Herbicidas/farmacologia , Norepinefrina/metabolismo , Feocromocitoma/metabolismo , Triazinas/farmacologia , 8-Bromo Monofosfato de Adenosina Cíclica/farmacologia , Animais , Sobrevivência Celular/efeitos dos fármacos , Colforsina/farmacologia , Dexametasona/farmacologia , Dopamina beta-Hidroxilase/metabolismo , Antagonismo de Drogas , Células PC12/efeitos dos fármacos , Células PC12/metabolismo , Feocromocitoma/patologia , Ratos , Tirosina 3-Mono-Oxigenase/metabolismo
11.
J Toxicol Sci ; 27(5): 449-57, 2002 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-12533915

RESUMO

A significant negative correlation between testicular interstitial cell tumors and pituitary tumors in control male F344 rats has been reported associated with the number of animals per cage. Change in numbers of animals per cage may cause stress and increased serum corticosteroids that can impair testosterone synthesis by interstitial cells. Eventual atrophy of interstitial cells may result in pituitary hyperfunction and tumor development. For relevant risk assessments, understanding the effect husbandry has on cellular processes is necessary. Twenty-four 6-week-old male F344 rats were housed individually, as pairs, or as trios for 13 weeks. Measured parameters included feed consumption, body and organ weights, hemograms, hormonal levels, histopathology, and cellular kinetics in the pituitary and testicle. Several caging-related differences occurred, that, although not statistically different, could be biologically significant; these included increased serum levels of estradiol, progesterone, and corticosterone; increased spermatogonial proliferation; decreased apoptosis within seminiferous tubules; and increased BrdU immunoreactivity of the interstitial cells. The statistically significant decrease in lymphocyte numbers correlated with the associated increase in corticosterone levels. This study indicates that the number of animals in a cage is associated with hormonal and cellular kinetic changes in the pituitary and testes, which could influence the incidence of tumors in these organs.


Assuntos
Hormônios/fisiologia , Abrigo para Animais , Pulmão/citologia , Animais , Antimetabólitos , Peso Corporal/fisiologia , Bromodesoxiuridina , Divisão Celular/fisiologia , Corticosterona/sangue , Ingestão de Alimentos/fisiologia , Estradiol/sangue , Cinética , Masculino , Neoplasias Hipofisárias/epidemiologia , Neoplasias Hipofisárias/patologia , Progesterona/sangue , Ratos , Ratos Endogâmicos F344 , Neoplasias Testiculares/epidemiologia , Neoplasias Testiculares/patologia
12.
Reprod Toxicol ; 47: 59-69, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24887032

RESUMO

Toxicology is increasingly focused on molecular events comprising adverse outcome pathways. Atrazine activates the hypothalamic-pituitary adrenal axis, but relationships to gonadal alterations are unknown. We characterized hormone profiles and adrenal (intact and castrate) and testis (intact) proteomes in rats after 3 days of exposure. The adrenal accounted for most of the serum progesterone and all of the corticosterone increases in intact and castrated males. Serum luteinizing hormone, androstenedione, and testosterone in intact males shared a non-monotonic response suggesting transition from an acute stimulatory to a latent inhibitory response to exposure. Eight adrenal proteins were significantly altered with dose. There were unique proteomic changes between the adrenals of intact and castrated males. Six testis proteins in intact males had non-monotonic responses that significantly correlated with serum testosterone. Different dose-response curves for steroids and proteins in the adrenal and testis reveal novel adverse outcome pathways in intact and castrated male rats.


Assuntos
Glândulas Suprarrenais/efeitos dos fármacos , Atrazina/toxicidade , Herbicidas/toxicidade , Testículo/efeitos dos fármacos , Glândulas Suprarrenais/metabolismo , Androstenodiona/sangue , Animais , Atrazina/sangue , Atrazina/farmacocinética , Castração , Corticosterona/sangue , Herbicidas/sangue , Herbicidas/farmacocinética , Hormônio Luteinizante/sangue , Masculino , Progesterona/sangue , Proteoma , Ratos Wistar , Testículo/metabolismo , Testosterona/sangue
13.
Neurotoxicol Teratol ; 34(3): 295-302, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22430068

RESUMO

Previous work has shown that a single oral administration of atrazine (ATR), a chlorotriazine herbicide, causes rapid increases in plasma adrenocorticotropic hormone (ACTH), serum corticosterone (CORT) and progesterone. The mechanism for these effects is unknown. To test whether administration of ATR causes hypothalamic-pituitary-adrenal (HPA) axis activation through the production of a generalized stress response resulting from gastrointestinal distress, we conducted both conditioned taste avoidance (CTA) and pica behavior experiments. Body temperature data were also collected to detect the presence of stress-induced hyperthermia. Adult male Wistar rats were given a single oral dose of ATR (0, 5, 25, 50, 100, or 200 mg/kg) or the primary ATR metabolite diamino-s-chlorotriazine (DACT; 135 mg/kg). Increases were observed in ACTH (LOEL, 12.5 mg/kg), CORT (LOEL, 5 mg/kg) and progesterone (LOEL, 5 mg/kg) 15 min following a single dose of ATR. DACT (135 mg/kg) increased ACTH (1.3-fold), CORT (2.9-fold) and progesterone (1.9-fold) above vehicle control concentrations, but the magnitude of the responses was much lower than that observed for an equal molar dose of ATR (200 mg/kg; 7.0, 9.0 and 11.0-fold above ACTH, CORT, progesterone controls, respectively). CTA results demonstrated conditioned taste avoidance to ATR, with a NOEL of 5 mg/kg. Animals dosed with DACT developed avoidance responses comparable to the highest dose of ATR. In the pica experiment, lower doses (5-50 mg/kg) of ATR had no effect on pica behavior, as measured 6 and 24 h post-dosing, nor did DACT. However, the highest dose of ATR (200 mg/kg) did induce pica behavior at both time points. No differences in body temperature were observed. Overall, results indicate that increases in ACTH and CORT secretion following administration of ATR occur at doses that are without effect on the display of pica behavior, indicating that the HPA-axis activation caused by ATR is not likely the result of gastrointestinal distress.


Assuntos
Atrazina/toxicidade , Comportamento Animal/efeitos dos fármacos , Herbicidas/toxicidade , Sistema Hipotálamo-Hipofisário/efeitos dos fármacos , Pica/induzido quimicamente , Sistema Hipófise-Suprarrenal/efeitos dos fármacos , Paladar/efeitos dos fármacos , Hormônio Adrenocorticotrópico/sangue , Animais , Aprendizagem da Esquiva/efeitos dos fármacos , Condicionamento Psicológico/efeitos dos fármacos , Corticosterona/sangue , Relação Dose-Resposta a Droga , Masculino , Progesterona/sangue , Ratos , Ratos Wistar
14.
Reprod Toxicol ; 31(2): 184-93, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21126571

RESUMO

Atrazine (2-chloro-4-ethylamino-6-isopropylamino-s-triazine) was introduced in the 1950s as a broad spectrum herbicide, and remains one of the most widely used herbicides in the United States. Several studies have suggested that atrazine modifies steroidogenesis and may disrupt reproductive function and development in a variety of species. A primary concern has been whether atrazine increases the synthesis of estrogens, perhaps by enhancing aromatase gene expression and activity. In this study, the effect of atrazine was compared in cultures using primary granulosa cells and H295R adrenal cortical carcinoma cells. Atrazine (10 µM), but not its metabolite, 2-chloro-4,6-diamino-1,2,5-triazine (DACT), significantly increased estradiol production and aromatase activity in granulosa cell cultures only when measured for 1-h following 24h of exposure. In H295R cells, atrazine (10 µM) increased estradiol and estrone production. Importantly, atrazine (10 µM) increased progesterone production from both cell types suggesting a broader effect of atrazine on steroidogenesis.


Assuntos
Neoplasias do Córtex Suprarrenal/metabolismo , Atrazina/toxicidade , Hormônios Esteroides Gonadais/biossíntese , Células da Granulosa/efeitos dos fármacos , Herbicidas/toxicidade , Esteroides/biossíntese , Animais , Aromatase/metabolismo , Atrazina/farmacologia , Linhagem Celular Tumoral , Células Cultivadas , Estradiol/biossíntese , Estrona/biossíntese , Feminino , Células da Granulosa/metabolismo , Herbicidas/farmacologia , Progesterona/biossíntese , Ratos
15.
Reprod Toxicol ; 32(1): 43-51, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21530638

RESUMO

Atrazine (ATR) is an herbicide that exerts negative reproductive effects. We examined the effects of vehicle or ATR (1, 5, 20 and 100mg/kg-d), administered to Sprague-Dawley rats on gestational days 14-21, once daily or divided into two doses per day, on female offspring reproductive indices. Offspring body weights at birth were reduced and mortality increased in the 100mg/kg-d group shortly after birth; by PND 21 there were no significant effects. Vaginal opening was delayed in this group, indicating delayed puberty. No significant differences in mammary gland development were apparent at PND 45, or estrous cyclicity through PND 272. There were no differences between dosing regimens. Lower ATR doses (0-20mg/kg-d) showed few effects in females prenatally exposed to ATR, while the high dose (100mg/kg-d) reduced offspring body weight and delayed vaginal opening. Nonetheless, it is unlikely that environmental exposure comparable to the high dose would be encountered.


Assuntos
Atrazina/toxicidade , Crescimento e Desenvolvimento/efeitos dos fármacos , Herbicidas/toxicidade , Reprodução/efeitos dos fármacos , Animais , Animais Recém-Nascidos , Peso Corporal/efeitos dos fármacos , Perda do Embrião/induzido quimicamente , Ciclo Estral/efeitos dos fármacos , Ciclo Estral/fisiologia , Feminino , Crescimento e Desenvolvimento/fisiologia , Longevidade/efeitos dos fármacos , Glândulas Mamárias Animais/efeitos dos fármacos , Glândulas Mamárias Animais/crescimento & desenvolvimento , Glândulas Mamárias Animais/patologia , Exposição Materna/efeitos adversos , Ratos , Ratos Sprague-Dawley , Reprodução/fisiologia , Maturidade Sexual/efeitos dos fármacos , Maturidade Sexual/fisiologia , Vagina/efeitos dos fármacos , Vagina/crescimento & desenvolvimento
16.
Reprod Toxicol ; 32(1): 52-63, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21530639

RESUMO

Few studies have investigated the long-term effects of atrazine (ATR) following in utero exposure. We evaluated the effects of gestational exposure of Sprague Dawley dams to ATR (0, 1, 5, 20, or 100mg/kg-d) on the reproductive development of male offspring. We also quantified the distribution of ATR and its chlorinated metabolites in maternal, fetal, and neonatal fluid and tissue samples following gestational and/or lactational exposure. Dose-dependent levels of chlorotriazines, primarily diamino-s-chlorotriazine, were present in most samples analyzed, including fetal tissue. In utero exposure to 1-20mg/kg-d ATR did not alter testosterone production, the timing of puberty, play behavior, or other androgen-dependent endpoints of male offspring. Significant maternal toxicity and postnatal mortality were observed at 100mg/kg-d. We conclude that, although levels of chlorotriazines within the fetus were considerable, gestational exposures of 1-20mg/kg-d do not lead to alterations in the measures of male development examined in this study.


Assuntos
Atrazina/toxicidade , Desenvolvimento Fetal/efeitos dos fármacos , Feto/efeitos dos fármacos , Genitália Masculina/efeitos dos fármacos , Herbicidas/toxicidade , Reprodução/efeitos dos fármacos , Animais , Animais Recém-Nascidos/crescimento & desenvolvimento , Animais Recém-Nascidos/metabolismo , Atrazina/farmacocinética , Comportamento Animal/efeitos dos fármacos , Comportamento Animal/fisiologia , Feminino , Desenvolvimento Fetal/fisiologia , Feto/embriologia , Feto/metabolismo , Genitália Masculina/embriologia , Genitália Masculina/crescimento & desenvolvimento , Herbicidas/farmacocinética , Masculino , Exposição Materna/efeitos adversos , Ratos , Ratos Sprague-Dawley , Reprodução/fisiologia , Testículo/efeitos dos fármacos , Testículo/metabolismo , Testosterona/metabolismo
17.
Reprod Toxicol ; 28(2): 180-7, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19409482

RESUMO

A protocol to evaluate the potential developmental and reproductive effects of test chemicals has been developed by the Life Stages Task Force of the International Life Sciences Institute (ILSI)/Health and Environmental Sciences Institute (HESI) Agricultural Chemical Safety Assessment (ACSA) Technical Committee. Since the original publication, several international groups have provided public comment on conducting the test. The extended one-generation reproductive toxicity test is now under consideration as a potential test guideline. The protocol uses a flexible approach that is markedly different from the current multigenerational guidelines. It encourages the use of toxicokinetics when setting the doses, evaluates more than one rat per sex per litter in the F1 offspring and does not necessarily require mating of the F1 to produce an F2 (F1 mating may be triggered by the presence of effects in the P0 and developing F1 rats). A number of additional reproductive endpoints, and the neurotoxicity and immunotoxicity cohorts are included. The ACSA protocol was developed with the goal of assuring that the methods are scientifically appropriate and the toxicological endpoints and exposure durations are relevant for risk assessment. Compared to existing testing strategies, the proposed approach uses substantially fewer animals, provides additional information on the neonate, juvenile and pubertal animal, and includes an estimation of human exposure potential for making decisions about the extent of testing required. In this paper, the evolution of the protocol since the 2006 publication is discussed. These changes reflect the collective input of a U.S. expert panel of government and industrial scientist convened in 2007 and discussions of an OECD expert group held in Paris, France (October, 2008).


Assuntos
Praguicidas/toxicidade , Reprodução/efeitos dos fármacos , Testes de Toxicidade/métodos , Animais , Conferências de Consenso como Assunto , Determinação de Ponto Final/métodos , Feminino , Guias como Assunto , Sistema Imunitário/efeitos dos fármacos , Sistema Imunitário/embriologia , Sistema Imunitário/crescimento & desenvolvimento , Masculino , Sistema Nervoso/efeitos dos fármacos , Sistema Nervoso/embriologia , Sistema Nervoso/crescimento & desenvolvimento , Praguicidas/farmacocinética , Ratos , Reprodução/fisiologia , Medição de Risco
18.
Toxicol Sci ; 112(1): 88-99, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19710361

RESUMO

Atrazine (ATR) has recently been shown to activate the hypothalamic-pituitary-adrenal (HPA) axis in rodents. The current study investigated the effect of ATR and two of its chlorinated metabolites, desisopropylatrazine (DIA) and diamino-s-chlorotriazine (DACT), on the HPA axis in the Long-Evans female rat. A single oral gavage administration of 75 mg/kg ATR or 60.2 mg/kg DIA (a dose equimolar to the applied ATR dose) during the morning of proestrus resulted in significant, acute increases in circulating adrenocorticotropic hormone (ACTH), corticosterone, and progesterone. Oral doses of ATR or DIA were given daily over the course of the 4-day ovarian cycle starting on the day of vaginal estrus, resulted in a similar, dose-responsive activation of the HPA axis. The increase in ACTH, corticosterone, and progesterone by these compounds was of a similar magnitude to that produced by 5-min restraint stress. Single or multiple oral exposures to DACT, on the other hand, did not significantly alter pituitary-adrenal hormone release. These results were observed despite plasma levels of DACT being higher than any other metabolite at the time of hormone measurement. Overall, circulating metabolite concentrations following equimolar dosing were much higher than those observed after ATR administration. Additional studies indicated that the activation of the HPA axis by oral exposure to ATR and DIA was not due simply to the stimulation of gastrointestinal afferents. Similar responses were observed in rats which received an oral dose of ATR following bilateral subdiaphramatic vagotomy and following intravenous administration of DIA in jugular vein catheterized animals. We conclude that ATR and the metabolite DIA significantly activate the HPA axis following oral exposure in the female rat. Activation of this endocrine axis by these chlorotriazines could contribute to the induced changes of female reproductive function reported previously.


Assuntos
Atrazina/toxicidade , Herbicidas/toxicidade , Sistema Hipotálamo-Hipofisário/efeitos dos fármacos , Sistema Hipófise-Suprarrenal/efeitos dos fármacos , Administração Oral , Animais , Atrazina/administração & dosagem , Atrazina/metabolismo , Feminino , Herbicidas/administração & dosagem , Herbicidas/metabolismo , Radioimunoensaio , Ratos , Ratos Long-Evans
19.
Toxicol Sci ; 107(1): 56-64, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18940961

RESUMO

Triclosan (5-chloro-2-(2,4-dichlorophenoxy)phenol) is a potent antibacterial and antifungal compound that is widely used in personal care products, plastics, and fabrics. Recently triclosan has been shown to alter endocrine function in a variety of species. The purpose of this study was to determine effects of triclosan on pubertal development and thyroid hormone concentrations in the male rat. Weanling rats were exposed to 0, 3, 30, 100, 200, or 300 mg/kg of triclosan by oral gavage from postnatal day (PND) 23 to 53. Preputial separation (PPS) was examined beginning on PND 33. Rats were killed on PND 53, organ weights were recorded and serum was collected for subsequent analysis. Triclosan did not affect growth or the onset of PPS. Serum testosterone was significantly decreased at 200 mg/kg, however no effects were observed on androgen-dependent reproductive tissue weights. Triclosan significantly decreased total serum thyroxine (T4) in a dose-dependent manner at 30 mg/kg and higher (no observed effect level of 3 mg/kg). Triiodothyronine (T3) was significantly decreased only at 200 mg/kg, but thyroid stimulating hormone was not statistically different at any dose. Liver weights were significantly increased at 100 mg/kg triclosan and above suggesting that the induction of hepatic enzymes may have contributed to the altered T4 and T3 concentrations, but it does not appear to correlate with the T4 dose-response. This study demonstrates that triclosan exposure does not alter androgen-dependent tissue weights or onset of PPS; however, triclosan exposure significantly impacts thyroid hormone concentrations in the male juvenile rat.


Assuntos
Maturidade Sexual/efeitos dos fármacos , Triclosan/farmacologia , Análise de Variância , Androstenodiona/sangue , Animais , Citocromo P-450 CYP2B1/metabolismo , Relação Dose-Resposta a Droga , Glucuronosiltransferase/metabolismo , Masculino , Microssomos Hepáticos/enzimologia , Ratos , Testículo/anatomia & histologia , Testosterona/sangue , Glândula Tireoide/anatomia & histologia , Tireotropina/sangue , Tiroxina/sangue , Triclosan/administração & dosagem , Tri-Iodotironina/sangue
20.
Toxicol Sci ; 104(1): 107-12, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18397915

RESUMO

In female rodents, hypothalamic norepinephrine (NE) has a role in stimulating the secretion of gonadotropin-releasing hormone (GnRH) that triggers the ovulatory surge of luteinizing hormone (LH). NE synthesis from dopamine (DA) is catalyzed by dopamine-beta-hydroxylase (DbetaH) which contains a copper cofactor. Sodium dimethyldithiocarbamate (DMDC) is a pesticide with metal chelating properties that has been found to reduce DbetaH activity. The resultant decrease in NE causes a suppression of both the LH surge and ovulation. The present study examined the dose-related impact of DMDC on hypothalamic GnRH neuronal activation indicated by the nuclear presence of the early gene product c-fos. It represents an essential link between effects on NE and suppression of the surge. Ovariectomized (OVX), estradiol-, and progesterone-primed Sprague-Dawley rats were given a single ip injection of 0, 3.6, 7.1, 14.2, or 28.4 mg/kg DMDC in separate groups of females to assess tissue GnRH/c-fos immunostaining, hypothalamic catecholamines, and serial blood samplings for LH. A dose-related decline in hypothalamic NE and increase in DA at 2 h after DMDC administration were consistent with a decrease in c-fos-positive GnRH neurons, with an almost complete absence of c-fos at the two highest doses. The effects correlated well with a suppression of the surge, although the percentage decrease in c-fos neurons at 7.1 mg/kg only attenuated the surge peak, not the overall amount of circulating LH. The present data offer further evidence that the impact of DMDC on the LH surge is central in origin and in doing so defines the toxic pathway for this effect on ovulation.


Assuntos
Dimetilditiocarbamato/toxicidade , Hormônio Liberador de Gonadotropina/metabolismo , Hipotálamo/efeitos dos fármacos , Hormônio Luteinizante/metabolismo , Neurônios/efeitos dos fármacos , Norepinefrina/metabolismo , Praguicidas/toxicidade , Animais , Feminino , Hipotálamo/metabolismo , Neurônios/metabolismo , Proteínas Proto-Oncogênicas c-fos/metabolismo , Ratos , Ratos Sprague-Dawley
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA